Role of phosphatidylinositol-3 kinase-γ in the actions of glucagon-like peptide-2 on the murine small intestine

American Journal of Physiology - Endocrinology and Metabolism

Volumn 292, Issue 6, 2007, Pages

  Anini, Younes ^a,c,d   Izzo, Angelo ^a   Oudit, Gavin Y ^a,b   Backx, Peter H ^a,b   Brubaker, Patricia L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Intestinal growth; Intestinal motility

Indexed keywords

CYCLIC AMP; GLUCAGON LIKE PEPTIDE 2; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; ENERGY YIELD; ENZYME ASSAY; GENE EXPRESSION; HETEROZYGOTE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; INTESTINE VILLUS; ISOLATED ORGAN; KNOCKOUT MOUSE; MOUSE; NONHUMAN; ORGAN GROWTH; ORGAN WEIGHT; PRIORITY JOURNAL; RNA TRANSCRIPTION; SMALL INTESTINE; STATISTICAL ANALYSIS; TREATMENT DURATION; WILD TYPE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL PROLIFERATION; CYCLIC AMP; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRANSIT; GLUCAGON-LIKE PEPTIDE 2; INTESTINAL MUCOSA; INTESTINE, SMALL; ISOENZYMES; MICE; MICE, KNOCKOUT; ORGAN SIZE; PEPTIDES; RECEPTORS, GLUCAGON; RNA, MESSENGER;

EID: 34447565150     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00429.2006     Document Type: Article

References (42)

1. Anini Y, Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 52: 252-259, 2003.
2. Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C, Camps M, Ruckle T, Schwarz MK, Rodriguez S, Martinez A, Balomenos D, Rommel C, Carrera AC. PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11: 933-935, 2005.
3. Benjamin MA, McKay DM, Yang PC, Cameron H, Perdue MH. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse. Gut 47: 112-119, 2000.
4. Bjerknes M, Cheng H. Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98: 12497-12502, 2001.
5. Boushey RP, Yusta B, Drucker DJ. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am J Physiol Endocrinol Metab 277: E937-E947, 1999.
6. Boushey RP, Yusta B, Drucker DJ. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. Cancer Res 61: 687-693, 2001.
7. Bozkurt A, Naslund E, Holst JJ, Hellstrom PM. GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. Regul Pept 107: 129-135, 2002.
8. Brock C, Schaefer M, Reusch HP, Czupalla C, Michalke M, Spicher K, Schultz G, Nurnberg B. Roles of Gβγ in membrane recruitment and activation of p110γ/p101 phosphoinositide 3-kinase γ. J Cell Biol 160: 89-99, 2003.
9. Brubaker PL, Izzo A, Hill M, Drucker DJ. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol Endocrinol Metab 272: E1050-E1058, 1997.
10. Burrin DG, Stoll B. Key nutrients and growth factors for the neonatal gastrointestinal tract. Clin Perinatol 29: 65-96, 2002.
11. Burrin DG, Stoll B, Guan X, Cui L, Chang X, Holst JJ. Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 146: 22-32, 2005.
12. Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J, Ferrandi C, Chabert C, Gillieron C, Francon B, Martin T, Gretener D, Perrin D, Leroy D, Vitte PA, Hirsch E, Wymann MP, Cirillo R, Schwarz MK, Rommel C. Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936 -943, 2005.
13. Crackower MA, Oudit GY, Kozieradzki I, Sarao R, Sun H, Sasaki T, Hirsch E, Suzuki A, Shioi T, Irie-Sasaki J, Sah R, Cheng HY, Rybin VO, Lembo G, Fratta L, Oliveira-dos-Santos AJ, Benovic JL, Kahn CR, Izumo S, Steinberg SF, Wymann MP, Backx PH, Penninger JM. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110: 737-749, 2002.
14. Dhanvantari S, Seidah NG, Brubaker PL. Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol 10: 342-355, 1996.
15. Dong DL, Wang QH, Chen W, Fan JJ, Mu JW, Ke J, Yang BF. Contrasting effects of tetraethylammonium and 4-aminopyridine on the gastrointestinal function of mice. Eur J Pharmacol 509: 179-185, 2005.
16. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93: 7911-7916, 1996.
17. Dube PE, Brubaker PL. Glucagon-like peptide-2 acutely activates PKB/ Akt and decreases apoptotic signaling in the mouse small intestine. Gastroenterology 128: 1295A, 2005.
18. Dube PE, Forse CL, Bahrami J, Brubaker PL. Essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131: 589-605, 2006.
19. Frey RS, Gao X, Javaid K, Siddiqui SS, Rahman A, Malik AB. Phosphatidylinositol 3-kinase γ signaling through protein kinase Cζ induces NADPH oxidase-mediated oxidant generation and NF-κB activation in endothelial cells. J Biol Chem 281: 16128-16138, 2006.
20. Garcia SB, Kawasaky MC, Silva JC, Garcia-Rodrigues AC, Borelli-Bovo TJ, Iglesias AC, Zucoloto S. Intrinsic myenteric denervation: a new model to increase the intestinal absorptive surface in short-bowel syndrome. J Surg Res 85: 200-203, 1999.
21. Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, Nichols BL, Burrin DG. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vaso-active peptides and mediates increased blood flow. Gastroenterology 130: 150-164, 2006.
22. Halls ML, Bathgate RA, Summers RJ. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms. Mol Pharmacol 70: 214-226, 2006.
23. Jasleen J, Shimoda N, Shen ER, Tavakkolizadeh A, Whang EE, Jacobs DO, Zinner MJ, Ashley SW. Signaling mechanisms of glucagon-like peptide 2-induced intestinal epithelial cell proliferation. J Surg Res 90: 13-18, 2000.
24. Jeppesen PB. Glucagon-like peptide-2: update of the recent clinical trials. Gastroenterology 130: S127-S131, 2006.
25. Kerfant BG, Gidrewicz D, Sun H, Oudit GY, Penninger JM, Backx PH. Cardiac sarcoplasmic reticulum calcium release and load are enhanced by subcellular cAMP elevations in PI3Kγ-deficient mice. Circ Res 96: 1079-1086, 2005.
26. L'Heureux MC, Brubaker PL. Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis. J Pharmacol Exp Ther 306: 347-354, 2003.
27. Li LX, MacDonald PE, Ahn DS, Oudit GY, Backx PH, Brubaker PL. Role of phosphatidylinositol 3-kinase γ in the β-cell: interactions with glucagon-like peptide-1. Endocrinology 147: 3318-3325, 2006.
28. Lund PK. Molecular basis of intestinal adaptation: the role of the insulin-like growth factor system. Ann NY Acad Sci 859: 18-36, 1998.
29. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 24: 91-98, 2002.
30. Martin GR, Wallace LE, Sigalet DL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol 286: G964-G972, 2004.
31. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, Crivici A. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96: 1569-1573, 1999.
32. Orskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ. GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124: 105-112, 2005.
33. Patrucco E, Notte A, Barberis L, Selvetella G, Maffei A, Brancaccio M, Marengo S, Russo G, Azzolino O, Rybalkin SD, Silengo L, Altruda F, Wetzker R, Wymann MP, Lembo G, Hirsch E. PI3Kγ modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118: 375-387, 2004.
34. Rocha FG, Shen KR, Jasleen J, Tavakkolizadeh A, Zinner MJ, Whang EE, Ashley SW. Glucagon-like peptide-2: divergent signaling pathways. J Surg Res 121: 5-12, 2004.
35. Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B, Wakeham A, Itie A, Bouchard D, Kozieradzki I, Joza N, Mak TW, Ohashi PS, Suzuki A, Penninger JM. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration. Science 287: 1040-1046, 2000.
36. Scott RB, Kirk D, MacNaughton WK, Meddings JB. GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol Gastrointest Liver Physiol 275: G911-G921, 1998.
37. Shin ED, Estall JL, Izzo A, Drucker DJ, Brubaker PL. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 128: 1340-1353, 2005.
38. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B, Gierschik P, Seedorf K, Hsuan JJ, Waterfield, MD, Wetzker R. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269: 690-693, 1995.
39. Tavares W, Drucker DJ, Brubaker PL. Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats. Am J Physiol Endocrinol Metab 278: E134-E139, 2000.
40. Walsh NA, Yusta B, DaCambra MP, Anini Y, Drucker DJ, Brubaker PL. Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology 144: 4385-4392, 2003.
41. Yang KY, Arcaroli J, Kupfner J, Pitts TM, Park JS, Strasshiem D, Perng RP, Abraham E. Involvement of phosphatidylinositol 3-kinase γ in neutrophil apoptosis. Cell Signal 15: 225-233, 2003.
42. Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119: 744-755, 2000.